Related Experiment Videos

[Percutaneous valvotomy of aortic valve stenoses in children]

J Kachaner1, A M Worms, F Bourlon

  • 1Service de cardiologie pédlatrique, hôpital Necker-Enfants malades, Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|May 1, 1996
PubMed

Insights

Percutaneous aortic valvuloplasty in children with aortic valve stenosis offers a safe alternative to surgery. While effective in reducing pressure gradients, long-term aortic valve function requires monitoring.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Aortic valve stenosis (AVS) is a significant congenital heart defect in children.
  • Traditional surgical interventions carry inherent risks and complexities.
  • Percutaneous aortic valvuloplasty (PAV) emerged as a less invasive therapeutic option.

Purpose of the Study:

  • To evaluate the efficacy and safety of percutaneous aortic valvuloplasty in pediatric patients.
  • To assess the long-term outcomes and complications associated with PAV.
  • To compare PAV with conventional surgical approaches for isolated aortic valve stenosis.

Main Methods:

  • Retrospective cooperative study involving 12 French centers from 1985.
  • Included 90 children (age > 3 months) with isolated aortic valve stenosis.
  • Retrograde femoral arterial approach with balloon angioplasty was the primary technique.

Main Results:

  • Significant reduction in peak transvalvular pressure gradients (average 39.2 mmHg).
  • Primary success rate of 60% (54 children), sustained in 88% of followed cases.
  • 17% immediate failures, 17% experienced significant aortic regurgitation.

Conclusions:

  • PAV is a simple, economical, and safe alternative to surgery for pediatric AVS.
  • PAV demonstrates lower immediate effectiveness compared to surgery.
  • Potential for long-term compromise of aortic valve function necessitates careful follow-up.

Related Concept Videos